It is well known that a high level of c-Myc is closely correlated with chemotherapy resistance in many cancers, including CRC cell [34–36], reminding that dysregulated low level of MAGI3 in CRC may reduce chemosensitivity through accumulation of c-Myc. The gene discussed is MYC; the disease is cancer.